Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BI 685509 in portal hypertension in decompensated cirrhosis with first decompensation
jRCT2031230564Active, not recruiting
- Sponsor
- Boehringer Ingelheim
- Start
- Jan 2024
- Modality
- Small Molecules
01
Overview
Randomised, double-blind trial in Portal Hypertension (PH) and Cirrhosis comparing BI 685509 with Placebo (2 arms). Started Jan 2024; status: active, not recruiting.
02
Drugs
avenciguat
03
Conditions
Portal Hypertension (PH)Cirrhosis
Beyond the preview
Go deeper on jRCT2031230564.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031230564.